Ciećko-Michalska I - Search Results

1

Intrahepatic expression of genes related to metabotropic receptors in chronic hepatitis.

Cieśla A, Kuśmider M, Faron-Górecka A, Dziedzicka-Wasylewska M, Bociąga-Jasik M, Owczarek D, Ciećko-Michalska I, Cibor D, Mach T. Cieśla A, et al. World J Gastroenterol. 2012 Aug 21;18(31):4156-61. doi: 10.3748/wjg.v18.i31.4156. World J Gastroenterol. 2012. PMID: 22919248 Free PMC article.

2

Efficacy of pegylated interferon alfa-2a or alfa-2b in combination with ribavirin in the treatment of chronic hepatitis caused by hepatitis C virus genotype 1b.

Mach TH, Cieśla A, Warunek W, Janas-Skulina U, Cibor D, Owczarek D, Ciećko-Michalska I. Mach TH, et al. Pol Arch Med Wewn. 2011 Dec;121(12):434-9. Pol Arch Med Wewn. 2011. PMID: 22157768 Free article. Clinical Trial.

3

[Serum cytokine concentration as prognostic factor in patients with alcoholic liver disease].

Ciećko-Michalska I, Szczepanek M, Cibor D, Owczarek D, Skulina D, Szczepański W, Michalski M. Ciećko-Michalska I, et al. Przegl Lek. 2006;63(5):249-52. Przegl Lek. 2006. PMID: 17036498 Polish.

4

Pathogenesis of hepatic encephalopathy.

Ciećko-Michalska I, Szczepanek M, Słowik A, Mach T. Ciećko-Michalska I, et al. Gastroenterol Res Pract. 2012;2012:642108. doi: 10.1155/2012/642108. Epub 2012 Dec 17. Gastroenterol Res Pract. 2012. PMID: 23316223 Free PMC article.

5

TGF-β1 and granulocyte elastase in the evaluation of activity of inflammatory bowel disease. A pilot study.

Ciećko-Michalska I, Wierzbicka-Tutka I, Szczepanek M, Fedak D, Jabłoński K, Cibor D, Mach T. Ciećko-Michalska I, et al. Postepy Hig Med Dosw (Online). 2014 Jan 23;68:66-72. doi: 10.5604/17322693.1086361. Postepy Hig Med Dosw (Online). 2014. PMID: 24491897 Free article.

6

[Neopterin in assessing the activity of inflammatory bowel diseases: ulcerative colitis and Crohn's disease].

Ciećko-Michalska I, Fedak D, Mach T. Ciećko-Michalska I, et al. Przegl Lek. 2010;67(12):1262-5. Przegl Lek. 2010. PMID: 21591350 Polish.

7

[Pathogenesis and diagnosis of subclinical hepatic encephalopathy].

Ciećko-Michalska I, Mach T, Słowik A. Ciećko-Michalska I, et al. Przegl Lek. 2010;67(2):131-4. Przegl Lek. 2010. PMID: 20557015 Review. Polish.

8

Optimal maintenance therapy in patients with non-erosive reflux disease reporting mild reflux symptoms--a pilot study.

Cibor D, Ciećko-Michalska I, Owczarek D, Szczepanek M. Cibor D, et al. Adv Med Sci. 2006;51:336-9. Adv Med Sci. 2006. PMID: 17357336 Clinical Trial.

9

Non-invasive diagnosis of steatosis, inflammatory changes and liver fibrosis in patients with non-alcoholic fatty liver diseases. Pilot study.

Ciećko-Michalska I, Szczepanek M, Wierzbicka-Tutka I, Zahradnik-Bilska J, Mach T. Ciećko-Michalska I, et al. Arch Med Sci Atheroscler Dis. 2018 Dec 28;3:e179-e183. doi: 10.5114/amsad.2018.81184. eCollection 2018. Arch Med Sci Atheroscler Dis. 2018. PMID: 30775610 Free PMC article.

10

Non-alcoholic fatty liver disease in Poland: how and at what stage is diagnosed, and how is treated. A survey study.

Ciećko-Michalska I, Szczepanek M, Tobiasz-Adamczyk B, Mach T. Ciećko-Michalska I, et al. Prz Gastroenterol. 2019;14(3):173-177. doi: 10.5114/pg.2019.88165. Epub 2019 Sep 27. Prz Gastroenterol. 2019. PMID: 31649787 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters